Sinusitis (Rhinosinusitis or Sinus Infection)

Sinusitis is a term meaning inflammation of the sinuses. Patients with environmental allergies can be at greater risk for sinusitis as they already have some inflammation present in their nasal passages. This baseline inflammation occurs due to a reaction to the environmental allergens around them.

When sinusitis has a duration of 4 weeks or less it is considered "acute" sinusitis. Sometimes relapses of symptoms or inflammation can occur, deeming the condition "recurrent." When symptoms last longer than 12 weeks, the condition is defined as “chronic” sinusitis.

Acute sinusitis is often due to a viral infection and usually resolves in 7-10 days with supportive symptom management (saline sinus rinses, decongestants, nasal sprays) and the body’s natural ability to fight off illness. If symptoms last longer than 10 days, there is more concern for a bacterial infection and an antibiotic may be prescribed. Interestingly, many cases of bacterial sinusitis may resolve without the use of antibiotics and complications rarely develop.

If your medical provider prescribes antibiotics and symptoms aren’t improving, follow up is indicated. Other serious symptoms that would require follow up include: fevers >102 F that persist longer than 3-4 days, swelling or redness around the eyelids, vision changes, facial drooping or facial muscle weakness, confusion, headache, or inability to move the head/neck.

Chronic sinusitis can develop after an upper respiratory infection, an acute sinusitis that fails to resolve, or slowly over months/years until it becomes a problem. Signs in adults can include: facial pain/pressure, decreased sense of smell, discolored anterior or posterior nasal mucous, nasal stuffiness or congestion. A persistent cough may also occur (especially in children).

Treatment for chronic sinusitis generally includes nasal washes, nasal steroid and possibly oral steroids and/or an extended course of antibiotics. In some cases, sinus surgery may also be needed.

Because chronic sinusitis is a complex disorder of inflammation in the sinuses, it can take a while to treat. If the chronic sinusitis does not improve, evaluation by an Ear, Nose and Throat specialist may be needed to evaluate for nasal polyps, blocked drainage pathways or other problems that predispose to chronic sinusitis.

Important Recall Notice for AIRSUPRA Inhalation Aerosol

AstraZeneca Pharmaceuticals LP, the maker of the inhalation medication AIRSUPRA® (albuterol and budesonide) aerosol, has initiated a voluntary recall for their product. This recall is effective immediately and involves multiple product lots. The recalled inhalers might not work properly.

Reason for Recall:

A defect in the delivery system of these inhalers has been identified, which may hinder the proper administration of the medication needed for effective asthma control.

Product Details:

Product Name: AIRSUPRA (albuterol and budesonide) inhalation aerosol

Strength: 90 mcg/80 mcg per inhalation

Packaging Types:

120-inhalation canister (NDC 0310-9080-12)

28-inhalation canister (NDC 0310-9080-28)

Recall Number: D-0444-2025

Affected Lot Numbers:

For 120-inhalation canisters: Lots: 6270044C00, 6270040D00, 6270034E00, Exp Date 10/2026; 6270053C00, 6270045C00, 6270047C00, 6270056C00, 6270052C00, 6270063E00 Exp 11/30/2026; 6270064C00, 6270071D00, 6270075D00, 6270075F00 Exp Date 12/31/2026; 6270107C00, Exp Date 9/30/2027

For 28-inhalation canisters: Lot 6270019E00, Exp Date 7/31/2025; 6270021D00, Exp 8/31/2025; 6270095C00, Exp 2/28/2026

Rx only, Manufactured for: AstraZeneca Pharmaceuticals LP, Wilmington, DE 19850, By: AstraZeneca Dunkerque Production (AZDP), Dunkerque, France, Product of France

What You Should Do:

Patients and users are advised not to use the inhalers associated with the affected lots. Please contact your pharmacy or healthcare provider as soon as possible to discuss alternative treatment options. Contact the dispensing pharmacy or AstraZeneca for return processing information.

If you are a current patient of the Oklahoma Allergy and Asthma Clinic affected by this recall, please give us a call at 405-235-0040.

Recall Contact Information:

For product questions, to report an adverse event or side effect, or to report a product quality issue, you can contact the AstraZeneca Information Center by phone at:

1-800-236-9933 (M-F, 8AM-6PM ET, excluding holidays)

Or you can report a product quality issue online: https://contactazmedical.astrazeneca.com/content/astrazeneca-champion/global/en/amp-form.html

For more information on this recall, please visit: https://www.accessdata.fda.gov/scripts/ires/?Event=96857

The post Important Recall Notice for AIRSUPRA Inhalation Aerosol appeared first on Oklahoma Allergy and Asthma Clinic.

Tags: News

Sinusitis (Rhinosinusitis or Sinus Infection)

Sinusitis (Rhinosinusitis or Sinus Infection)

Conditions Treated

Recent News

Important Recall Notice for AIRSUPRA Inhalation Aerosol

Reason for Recall:

Product Details:

What You Should Do:

Recall Contact Information:

Notice of Nondiscrimination

GET SOCIAL

USEFUL LINKS

CONTACT US

Main Office